Xiaoyuan “Kate” Ding’s practice focuses on preparation and prosecution of U.S. and foreign patent applications in a wide variety of chemical fields, including organic chemistry, analytical chemistry, materials chemistry, physical chemistry, inorganic chemistry, nanotechnology, catalysis, sensors, and spectroscopy.
Prior to joining the firm, Kate spent eight years working at Microbiotix Inc., Worcester, Massachusetts, as a research scientist developing novel chemical agents against a wide range of disease-causing bacteria (e.g., Acinetobacter baumannii), viruses (e.g., Ebola) and parasites (e.g., malaria). Before that, she worked at Pfizer Inc., Groton, Connecticut, for two years as a senior research associate building libraries of new antibacterial drug analogs against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
Kate is a co-author of more than ten scientific articles published in such prestigious journals as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry, and Journal of Physical Chemistry. Kate obtained her license to practice before the U.S. Patent and Trademark Office while working at Microbiotix, where she was named as a co-inventor in PCT, U.S., and foreign patent applications for five inventions.